Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64565acdcc52331729793a894d422711 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate |
2014-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cde3124db794e502b1b53ec5befa83ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d3ea65448ea25cb6e45cfe65c4d628 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c726e66da6e84107b371e14a28390e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5576afc39688df73c511b73afbdca765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9810377b8887d7bc5764722e55baa498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aafe43b4f7af4c8b535d7c841730eba8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396e85362ba515238c35a0246036dd0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59211ef0d74b76af31e56d65ea400892 |
publicationDate |
2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014251532-A1 |
titleOfInvention |
Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
abstract |
The present invention relates to a film preparation for oral administration, containing tadalafil free base, and a preparation method therefor. By adding a polyethylene glycol-based polymer and/or a vinyl pyrrolidone-based polymer as a dispersion stabilizer, it is possible to: maximize the dispersion stability of tadalafil free base in a film by using a small amount without inducing a specific odor or taste which can occur when using other dispersion stabilizers known in the relevant art; provide a film having an extremely low rate of tadalafil free base particle reaggregation; and remarkably reduce the amount of bubbles during a preparation process. |
priorityDate |
2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |